Video

Dr. Brahmer Discusses Managing Immunotherapy AEs

Julie R. Brahmer, MD, from Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, discusses the management of adverse events (AEs) from treatment with immunotherapies.

Julie R. Brahmer, MD, from Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, discusses the management of adverse events (AEs) from treatment with immunotherapies.

Currently, Brahmer says she is taking a multidisciplinary approach to manage AEs, as she is not as experienced as some melanoma and renal cell carcinoma doctors, who have been treating with immunotherapies for some time.

Brahmer says it is beneficial to have other physicians to go to if any questions arise, such as a dermatologist, pulmonologist, or hepatologist. Over time, lung cancer doctors will become more comfortable in this space.

Related Videos
Howard S. Hochster, MD, FACP,
John H. Strickler, MD
Brandon G. Smaglo, MD, FACP
Cedric Pobel, MD
Ruth M. O’Regan, MD
Michael R. Grunwald, MD, FACP
Peter Forsyth, MD
John N. Allan, MD
Dr Dorritie on the Clinical Implications of the 5-Year Follow-Up Data From CAPTIVATE in CLL/SLL
Minoo Battiwalla, MD, MS